Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial.

Derek BrownAdriana ZingoneYunkai YuBin ZhuJulián CandiaLiang CaoBríd M Ryan

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2018)

Circulating inflammation proteins are unlikely to have utility as companion LDCT biomarkers.

Keyphrases

oxidative stress
clinical trial
study protocol
quality improvement
randomized controlled trial
phase ii